4.5 Article

Antiparkinsonian activity of Cucurbita pepo seeds along with possible underlying mechanism

Journal

METABOLIC BRAIN DISEASE
Volume 36, Issue 6, Pages 1231-1251

Publisher

SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s11011-021-00707-6

Keywords

Haloperidol; Cucurbita pepo; Parkinson's disease; PCR; Molecular docking; ADMET

Ask authors/readers for more resources

The study demonstrated that methanolic extract of Cucurbita pepo seeds could improve motor function in a Parkinson rat model by regulating biochemical indicators and molecular pathways, suggesting its potential as a candidate drug for the treatment of Parkinson's disease.
Cucurbita pepo is used as a vegetable in Pakistan and its seeds are also rich in tocopherol. Data showed the pivotal role of tocopherol in the treatment of Parkinson's disease (PD). The current study was designed to probe into the antiparkinson activity of methanolic extract of C. pepo (MECP) seeds in the haloperidol-induced Parkinson rat model. Behavioral studies showed improvement in motor functions. The increase in catalase, superoxide dismutase, glutathione levels whereas the decreases in the malondialdehyde and nitrite levels were noted in a dose-dependent manner. Acetylcholine-esterase (AchE) activity was increased. Molecular docking results revealed significant binding interaction of selected phytoconstituents within an active site of target protein AchE (PDB ID: 4EY7). Furthermore, alpha-synuclein was up regulated with down regulation of TNF-alpha and IL-1 beta in the qRT-PCR study. Subsequently, ADMET results on the basis of structure to activity predictions in terms of pharmacokinetics and toxicity estimations show that selected phytochemicals exhibited moderately acceptable properties. These properties add knowledge towards the structural features which could improve the bioavailability of selected phytochemicals before moving towards the initial phase of the drug development. Our integrated drug discovery scheme concluded that C. pepo seeds could ameliorate symptoms of PD and may prove a lead remedy for the treatment of PD.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available